These findings suggest that exosome-derived salivary miRNA could serve as a reliable and, most importantly, non-invasive evaluation tool of prostate cancer screening results (e.g., PSA serum measurements) under the concept of liquid biopsy [59]. Here, KLK3 is linked to prostate carcinoma.